UB Paderborn / Katalog / Suche / in CDI

Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

Journal of translational medicine, 2020-04, Vol.18 (1), p.176-176, Article 176

2020

Link zum Volltext

Verfügbarkeit prüfen

Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury

Stem cells (Dayton, Ohio), 2010-01, Vol.28 (1), p.152-163

2010

Link zum Volltext

Verfügbarkeit prüfen

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (1), p.2198467-2198467

2023

Link zum Volltext

Verfügbarkeit prüfen

Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury

The Journal of neuroscience, 2005-05, Vol.25 (19), p.4694-4705

2005

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Journal of experimental & clinical cancer research, 2022-12, Vol.41 (1), p.344-9

2022

Link zum Volltext

Verfügbarkeit prüfen

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

Glia, 2005-02, Vol.49 (3), p.385-396

2005

Link zum Volltext

Verfügbarkeit prüfen

Co-grafts of Human Embryonic Stem Cell Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons Rats

Frontiers in neuroscience, 2021-10, Vol.15, p.752958-752958

2021

Link zum Volltext

Verfügbarkeit prüfen

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

Human vaccines & immunotherapeutics, 2020-04, Vol.16 (4), p.742-755

2020

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Journal for immunotherapy of cancer, 2018-03, Vol.6 (1), p.19-19, Article 19

2018

Link zum Volltext

Verfügbarkeit prüfen

Retinal Organoids Long-Term Functional Characterization Using Two-Photon Fluorescence Lifetime and Hyperspectral Microscopy

Frontiers in cellular neuroscience, 2021-12, Vol.15, p.796903-796903

2021

Link zum Volltext

Verfügbarkeit prüfen

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Human vaccines & immunotherapeutics, 2022-11, Vol.18 (6), p.2100189-2100189

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma

Journal of surgical oncology, 2015-06, Vol.111 (7), p.862-867

2015

Link zum Volltext

Verfügbarkeit prüfen

1411 Feasibility, safety, and efficacy of personal vaccines consisting of autologous dendritic cells loaded ex vivo with autologous tumor antigens from self-renewing cancer cells

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1569-A1569

2023

Link zum Volltext

Verfügbarkeit prüfen

333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A359-A359

2021

Link zum Volltext

Verfügbarkeit prüfen

952 Phase II trial of AV-GBM-1: dendritic cell vaccine pulsed with lysate enriched for autologous tumor-initiating cell antigens in the treatment of patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A1001-A1001

2021

Link zum Volltext

Verfügbarkeit prüfen

335 Leukaphereses to obtain monocytes to produce dendritic cells in manufacturing of personal autologous AV-GBM-1 vaccines in a phase II trial in patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A361-A361

2021

Link zum Volltext

Verfügbarkeit prüfen

331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A357-A357

2021

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell vaccines for melanoma: past, present and future

Melanoma management, 2016-12, Vol.3 (4), p.273-289

2016

Link zum Volltext

Verfügbarkeit prüfen

Derivation of high purity neuronal progenitors from human embryonic stem cells

PloS one, 2011-06, Vol.6 (6), p.e20692-e20692

2011

Link zum Volltext

Verfügbarkeit prüfen

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A345-A345

2020

Link zum Volltext

Verfügbarkeit prüfen

Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis

Experimental neurology, 2004-06, Vol.187 (2), p.254-265

2004

Link zum Volltext

Verfügbarkeit prüfen

Derivation of high-purity oligodendroglial progenitors

Methods in molecular biology (Clifton, N.J.), 2009, Vol.549, p.59

2009

Link zum Volltext

Verfügbarkeit prüfen

Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells

PloS one, 2011-01, Vol.6 (1), p.e14499-e14499

2011

Link zum Volltext

Verfügbarkeit prüfen

Human Motor Neuron Progenitor Transplantation Leads to Endogenous Neuronal Sparing in 3 Models of Motor Neuron Loss

Stem cells international, 2011-01, Vol.2011, p.207230-11

2011

Link zum Volltext

Verfügbarkeit prüfen

Ascending central canal dilation and progressive ependymal disruption in a contusion model of rodent chronic spinal cord injury

BMC neurology, 2007-09, Vol.7 (1), p.30-30, Article 30

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cell Transplants Improve Recovery after Cervical Spinal Cord Injury

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines

Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

Co-grafts of Human Embryonic Stem Cell Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient Retinal Degenerate Royal College of Surgeons Rats

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses

Retinal Organoids Long-Term Functional Characterization Using Two-Photon Fluorescence Lifetime and Hyperspectral Microscopy

A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma

1411 Feasibility, safety, and efficacy of personal vaccines consisting of autologous dendritic cells loaded ex vivo with autologous tumor antigens from self-renewing cancer cells

333 Changes in proteomic markers after injections of personal AV-GBM-1 dendritic cell/tumor initiating cell vaccines in a phase II trial in patients with newly diagnosed glioblastoma

952 Phase II trial of AV-GBM-1: dendritic cell vaccine pulsed with lysate enriched for autologous tumor-initiating cell antigens in the treatment of patients with newly diagnosed glioblastoma

335 Leukaphereses to obtain monocytes to produce dendritic cells in manufacturing of personal autologous AV-GBM-1 vaccines in a phase II trial in patients with newly diagnosed glioblastoma

331 Tumor markers associated with increased survival in a phase II trial of dendritic cell/tumor-initiating-cell vaccine AV-GBM-1 in patients with newly diagnosed glioblastoma

Dendritic cell vaccines for melanoma: past, present and future

Derivation of high purity neuronal progenitors from human embryonic stem cells

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis

Derivation of high-purity oligodendroglial progenitors

Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells

Human Motor Neuron Progenitor Transplantation Leads to Endogenous Neuronal Sparing in 3 Models of Motor Neuron Loss

Ascending central canal dilation and progressive ependymal disruption in a contusion model of rodent chronic spinal cord injury

Suchergebnisse filtern